Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Patel Sanjiv Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 4 Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 1,662 shares @ $10.68, valued at $17.8k
02/09/2023 4 Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 14,000 shares @ $21.45, valued at $300.3k
Sold 14,000 shares @ $20.98, valued at $293.7k
Sold 14,000 shares @ $20.55, valued at $287.7k
Exercised 14,000 options to buy @ $5.04, valued at $70.6k
Exercised 14,000 options to buy @ $5.04, valued at $70.6k
Exercised 14,000 options to buy @ $5.04, valued at $70.6k
01/19/2023 4 Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 28,000 shares @ $20.23, valued at $566.4k
Sold 28,000 shares @ $20.87, valued at $584.4k
Sold 28,000 shares @ $20.02, valued at $560.6k
Exercised 28,000 options to buy @ $5.04, valued at $141.1k
Exercised 28,000 options to buy @ $5.04, valued at $141.1k
Exercised 28,000 options to buy @ $5.04, valued at $141.1k
Granted 701,680 options to buy @ $20.45, valued at $14.3M
10/13/2022 4 Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 14,000 shares @ $21.36, valued at $299k
Sold 14,000 shares @ $21.18, valued at $296.5k
Sold 14,000 shares @ $20.58, valued at $288.1k
Exercised 14,000 options to buy @ $4.12, valued at $57.7k
Exercised 14,000 options to buy @ $4.12, valued at $57.7k
Exercised 14,000 options to buy @ $4.12, valued at $57.7k
09/15/2022 4 Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 14,000 shares @ $25.45, valued at $356.3k
Sold 14,000 shares @ $23.47, valued at $328.6k
Sold 14,000 shares @ $23.8, valued at $333.2k
Exercised 14,000 options to buy @ $4.12, valued at $57.7k
Exercised 14,000 options to buy @ $4.12, valued at $57.7k
Exercised 14,000 options to buy @ $4.12, valued at $57.7k
07/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2022 4 Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Sold 28,000 shares @ $31.8, valued at $890.4k
Sold 14,000 shares @ $31.96, valued at $447.4k
Sold 14,000 shares @ $31.94, valued at $447.2k
Sold 14,000 shares @ $30.51, valued at $427.1k
Exercised 28,000 options to buy @ $4.12, valued at $115.4k
Exercised 14,000 options to buy @ $4.12, valued at $57.7k
Exercised 14,000 options to buy @ $5.04, valued at $70.6k
Exercised 14,000 options to buy @ $4.12, valued at $57.7k
Exercised 14,000 options to buy @ $5.04, valued at $70.6k
01/31/2022 4 Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 527,140 options to buy @ $20.38, valued at $10.7M
01/07/2022 4 Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 658 shares @ $26.1, valued at $17.2k
07/12/2021 3 Patel Sanjiv (Director) has filed a Form 3 on ARYA Sciences Acquisition Corp V
05/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
03/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/15/2020 4 Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Granted 753,804 options to buy @ $5.22, valued at $3.9M
07/21/2020 4 Patel Sanjiv (President and CEO) has filed a Form 4 on Relay Therapeutics, Inc.
Txns: Bought 25,000 shares @ $20, valued at $500k
07/15/2020 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy